News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,699 Results
Type
Article (38292)
Company Profile (167)
Press Release (446240)
Multimedia
Podcasts (55)
Webinars (10)
Section
Business (135838)
Career Advice (1132)
Deals (22571)
Drug Delivery (74)
Drug Development (57764)
Employer Resources (99)
FDA (13036)
Job Trends (10671)
News (233932)
Policy (22261)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (1953)
Accelerated approval (4)
Adcomms (18)
Allergies (76)
Alliances (35919)
ALS (75)
Alzheimer's disease (1029)
Antibody-drug conjugate (ADC) (117)
Approvals (13054)
Artificial intelligence (232)
Autoimmune disease (20)
Automation (7)
Bankruptcy (200)
Best Places to Work (8247)
BIOSECURE Act (19)
Biosimilars (57)
Biotechnology (133)
Bladder cancer (70)
Brain cancer (25)
Breast cancer (226)
Cancer (1851)
Cardiovascular disease (155)
Career advice (926)
Career pathing (24)
CAR-T (129)
Cell therapy (353)
Cervical cancer (20)
Clinical research (47930)
Collaboration (686)
Compensation (223)
Complete response letters (16)
COVID-19 (1846)
CRISPR (27)
C-suite (217)
Cystic fibrosis (65)
Data (1779)
Decentralized trials (2)
Denatured (22)
Depression (43)
Diabetes (200)
Diagnostics (4037)
Digital health (12)
Diversity (7)
Diversity, equity & inclusion (30)
Drug discovery (97)
Drug pricing (66)
Drug shortages (21)
Duchenne muscular dystrophy (78)
Earnings (46641)
Editorial (31)
Employer branding (11)
Employer resources (94)
Events (72074)
Executive appointments (632)
FDA (14105)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (619)
Gene editing (74)
Generative AI (19)
Gene therapy (251)
GLP-1 (567)
Government (3295)
Grass and pollen (3)
Guidances (43)
Healthcare (13362)
Huntington's disease (21)
IgA nephropathy (26)
Immunology and inflammation (96)
Indications (25)
Infectious disease (1951)
Inflammatory bowel disease (123)
Inflation Reduction Act (5)
Influenza (42)
Intellectual property (73)
Interviews (162)
IPO (9698)
IRA (25)
Job creations (2753)
Job search strategy (851)
Kidney cancer (11)
Labor market (27)
Layoffs (291)
Leadership (14)
Legal (4414)
Liver cancer (63)
Lung cancer (274)
Lymphoma (122)
Machine learning (4)
Management (33)
Manufacturing (210)
MASH (61)
Medical device (13081)
Medtech (13084)
Mergers & acquisitions (13291)
Metabolic disorders (562)
Multiple sclerosis (66)
NASH (16)
Neurodegenerative disease (82)
Neuropsychiatric disorders (16)
Neuroscience (1476)
NextGen: Class of 2025 (4682)
Non-profit (3012)
Northern California (1850)
Now hiring (23)
Obesity (291)
Opinion (210)
Ovarian cancer (62)
Pain (74)
Pancreatic cancer (66)
Parkinson's disease (114)
Partnered (15)
Patents (168)
Patient recruitment (90)
Peanut (41)
People (44910)
Pharmaceutical (29)
Pharmacy benefit managers (11)
Phase I (14817)
Phase II (21065)
Phase III (16103)
Pipeline (935)
Policy (108)
Postmarket research (1782)
Preclinical (5450)
Press Release (62)
Prostate cancer (93)
Psychedelics (31)
Radiopharmaceuticals (197)
Rare diseases (299)
Real estate (4437)
Recruiting (42)
Regulatory (16230)
Reports (27)
Research institute (1809)
Resumes & cover letters (180)
Rett syndrome (2)
RNA editing (4)
RSV (31)
Schizophrenia (57)
Series A (114)
Series B (77)
Service/supplier (7)
Sickle cell disease (38)
Southern California (1657)
Special edition (12)
Spinal muscular atrophy (119)
Sponsored (19)
Startups (3054)
State (1)
Stomach cancer (12)
Supply chain (48)
Tariffs (24)
The Weekly (33)
United States (16905)
Vaccines (486)
Venture capitalists (41)
Weight loss (204)
Women's health (22)
Worklife (9)
Date
Today (157)
Last 7 days (613)
Last 30 days (1927)
Last 365 days (25063)
2025 (7748)
2024 (26680)
2023 (29791)
2022 (38679)
2021 (41347)
2020 (38770)
2019 (32996)
2018 (25364)
2017 (23645)
2016 (22568)
2015 (26209)
2014 (22063)
2013 (19281)
2012 (18067)
2011 (18606)
2010 (16967)
Location
Africa (548)
Alabama (39)
Alaska (5)
Arizona (132)
Arkansas (11)
Asia (31081)
Australia (5348)
California (4297)
Canada (1533)
China (459)
Colorado (181)
Connecticut (212)
Delaware (130)
Europe (65371)
Florida (650)
Georgia (144)
Idaho (40)
Illinois (427)
India (23)
Indiana (271)
Iowa (5)
Japan (139)
Kansas (77)
Kentucky (14)
Louisiana (10)
Maine (29)
Maryland (752)
Massachusetts (3225)
Michigan (163)
Minnesota (363)
Mississippi (2)
Missouri (55)
Montana (25)
Nebraska (20)
Nevada (36)
New Hampshire (66)
New Jersey (1342)
New Mexico (18)
New York (1270)
North Carolina (746)
North Dakota (5)
Northern California (1850)
Ohio (157)
Oklahoma (9)
Oregon (27)
Pennsylvania (1002)
Puerto Rico (7)
Rhode Island (29)
South America (775)
South Carolina (21)
Southern California (1657)
Tennessee (81)
Texas (655)
Utah (131)
Virginia (88)
Washington D.C. (47)
Washington State (453)
West Virginia (3)
Wisconsin (42)
484,699 Results for "biote medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biote Schedules First Quarter 2025 Financial Results Release and Conference Call
April 23, 2025
·
3 min read
Press Releases
Biote Announces CEO Retirement and Succession Plan
January 30, 2025
·
5 min read
Press Releases
Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call
February 27, 2025
·
3 min read
Press Releases
Biote Reports Third Quarter 2024 Financial Results
November 12, 2024
·
19 min read
Business
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on Tuesday, May 7, 2024, after the close of the market.
April 23, 2024
·
3 min read
Business
Biote Reports First Quarter 2024 Financial Results
Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
20 min read
BioMidwest
BioT Medical Awarded 2023 AWS Rising Star Partner of the Year
BioT Medical, a leader in cloud-powered medical devices, is proud to announce that it has been named the Rising Star Partner of the Year in the 2023 Geo and Global AWS Partner Awards.
November 27, 2023
·
2 min read
Press Releases
Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call
October 29, 2024
·
3 min read
Lone Star Bio
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that management expects 2023 revenue and Adjusted EBITDA to be slightly below prior guidance.
January 17, 2024
·
9 min read
Business
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the fourth quarter and full year ended December 31, 2023.
March 12, 2024
·
24 min read
1 of 48,470
Next
